Literature DB >> 4022395

Muscle mitochondria from patients with Duchenne muscular dystrophy have a normal beta oxidation, but an impaired oxidative phosphorylation.

H R Scholte, I E Luyt-Houwen, H F Busch, F G Jennekens.   

Abstract

Entities:  

Mesh：

Year:  1985        PMID： 4022395     DOI： 10.1212/wnl.35.9.1396

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

1.  Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse.

Authors:  A V Kuznetsov; K Winkler; F R Wiedemann; P von Bossanyi; K Dietzmann; W S Kunz
Journal:  Mol Cell Biochem       Date:  1998-06       Impact factor: 3.396

Review 2.  The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth.

Authors:  Sam Amin; Andrew Lux; Finbar O'Callaghan
Journal:  Br J Clin Pharmacol       Date:  2018-11-08       Impact factor: 4.335

Review 3.  Nitric oxide in myogenesis and therapeutic muscle repair.

Authors:  Clara De Palma; Emilio Clementi
Journal:  Mol Neurobiol       Date:  2012-07-22       Impact factor: 5.590

4.  BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy.

Authors:  Marco Segatto; Roberta Szokoll; Raffaella Fittipaldi; Cinzia Bottino; Lorenzo Nevi; Kamel Mamchaoui; Panagis Filippakopoulos; Giuseppina Caretti
Journal:  Nat Commun       Date:  2020-11-30       Impact factor: 14.919

5.  Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study.

Authors:  Patricia Hafner; Ulrike Bonati; Beat Erne; Maurice Schmid; Daniela Rubino; Urs Pohlman; Thomas Peters; Erich Rutz; Stephan Frank; Cornelia Neuhaus; Stefanie Deuster; Monika Gloor; Oliver Bieri; Arne Fischmann; Michael Sinnreich; Nuri Gueven; Dirk Fischer
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.